Have a personal or library account? Click to login

Total Psoas Area and Psoas Density Assessment in COVID-19 Patients Using CT Imaging – Could Muscle Mass Alteration During Intensive Care Hospitalization be Determined?

Open Access
|Nov 2023

Figures & Tables

Fig.1.

Flow chart
Flow chart

Fig. 2.

CT psoas muscle evaluation at the third lumbar vertebrae. A. Cross-sectional area evaluation showing muscle area. B. Evaluation of muscle density in Hounsfiled unit.
CT psoas muscle evaluation at the third lumbar vertebrae. A. Cross-sectional area evaluation showing muscle area. B. Evaluation of muscle density in Hounsfiled unit.

Fig. 3.

Box-plot comparing right and left changes in psoas muscle area (A) and psoas muscle HU (B).
Box-plot comparing right and left changes in psoas muscle area (A) and psoas muscle HU (B).

Fig. 4.

AUC-ROC for psoas area and IMV. A. IMV <24 hours. B. IMV 24-96 hours. C. IMC >96 hours.
AUC-ROC for psoas area and IMV. A. IMV <24 hours. B. IMV 24-96 hours. C. IMC >96 hours.

Fig. 5.

AUC-ROC for psoas HU and IMV. A. IMV <24 hours. B. IMV 24-96 hours. C. IMC >96 hours.
AUC-ROC for psoas HU and IMV. A. IMV <24 hours. B. IMV 24-96 hours. C. IMC >96 hours.

Fig. 6.

Right and left psoas analysis (area - A and HU - B) linked to the patients outcome
Right and left psoas analysis (area - A and HU - B) linked to the patients outcome

AUC-ROC for psoas HU and IMV duration

IMV duration (hours)Psoas (HU)CriterionAUC-ROC95% CIPSn95% CISp95% CI
<24Right>−0.010.8500.640–0.9630.0001100.0029.2–100.075.0050.9–91.3
Left>−7.5150.6830.458–0.8590.29100.0029.2–100.040.0019.1–63.9

24–96Right≤−2.6750.5950.373–0.7920.53100.0015.8–100.047.6225.7–70.2
Left>−5.5050.5480.329–0.7540.70100.0015.8–100.047.6225.7–70.2

>96Right≤−4.120.7150.491–0.8820.04969.2338.6–90.970.0034.8–93.3
Left≤−4.270.6230.399–0.8140.3169.2338.6–90.960.0026.2–87.8

Dynamic changes in total psoas area and psoas HU in two CT scan evaluations

CT scan parameterCT1 (A+B) Mean±SDCT2 (A+B) Mean±SDDifference Meanp difference 1st and 2nd
Right TPA(cm2)7.82±2.767.70±2.90−0.120.88
Left TPA(cm2)8.52±3.567.92±3.20−0.590.56
Right psoas HU37.4±10.2133.16±10.31−4.240.17
Left psoas HU39.9±10.0635.93±9.33−3.990.17

AUC-ROC for the Psoas area and IMV duration

IMV duration (hours)Psoas area (cm2)CriterionAUC-ROC95% CIpSn95% CISp95% CI
<24Right>−0.6540.5830.362–0.7830.53100.0029.2–100.040.0019.1–63.9
Left≤−1.2050.6670.442–0.8470.3966.679.4–99.280.0056.3–94.3

24–96Right>0.2750.9290.741–0.9940.0001100.0015.8–100.085.7163.7–97.0
Left>0.3070.8330.621–0.9540.0001100.0015.8–100.080.9558.1–94.6

>96Right≤−0.6540.6000.377–0.7960.4353.8525.1–80.890.0055.5–99.7
Left>0.5990.5080.294–0.7200.95123.085.0–53.8100.0069.2–100.0

AUC-ROC for the negative outcome (deceased patients)

CT scan parameterCriterionAUC-ROC95% CIPSn95% CISp95% CI
Right psoas area>−0.450.5710.351–0.7730.61056.229.9–80.271.429.0–96.3
Right psoas HU>−12.590.5710.350–0.7730.63381.254.4–96.042.99.9–81.6
Left psoas area>−0.3190.5090.295–0.7210.94443.719.8–70.185.742.1–99.6
Left psoas HU>−10.350.6430.418–0.8290.36293.769.8–99.857.118.4–90.1

Patients’ characteristics

DemographicsAll patients (n=22)
Male sex (n, %)8 (36.4%)
Age (years, mean±SD)71.09±10.57

ICU admission diagnostics

ARF (n, %)11 (50%)
Other (n, %)11 (50%)

Severity scores

qCSI (mean±SD)8.73±2.27
CHOSEN score (median (min-max))13 (1–44)
modified CHOSEN score (mean±SD)19.33±9.81

Hospital stay characteristics

LOS in Hospital (days) (median (min-max))18 (10–91)
LOS in ICU (days) (median (min-max))11 (2–91)
Time period between CTpsoas1 and CT psos2 (days) (medain (min-max))10 (3–19)

ICU admission oxygenation

Facial mask (n, %)9 (40.9%)
NIV-CPAP (n, %)2 (9.1%)
IMV (n, %)11 (50%)

ICU stay oxygenation

Need for NIV-CPAP (n, %)5 (22.7%)
Need for IMV (n, %)18 (81.8%)
IMV <24 hours3 (13.6%)
IMV 24–96 hours2 (9.1%)
IMV >96 hours13 (59.1%)

Admission laboratory report

WBC (mean±SD)12.307±8.421
Neutrophils (mean±SD)10.381±7.924
Lymphocytes (mean±SD)0.958±0.783
Platelets (median (min-max))262.500 (90.000–1081.000)
NLR (median (min-max))10.537 (3.758–66.631)
PLR (median (min-max))382.907 (59.644–1184.2100)
SII (median (min-max))2361.589 (474.000–42981.947)
CRP (median (min-max))106.810 (5.660–353.300)
Creatinine (median (min-max))1.025 (0.140–8.160)
Glucose (mean±SD)149.136±73.879

Assessment of total psoas area and psoas HU in the first and second CT scan

CT scan parameterInvestigator A Mean±SDInvestigator B Mean±SDMean Differencep difference A and B
Right TPA1(cm2)8.01±2.707.72±2.97−0.290.73
Right TPA2(cm2)8.39±3.197.08±2.92−1.310.15
Left TPA1(cm2)8.71±3.808.41±3.42−0.290.78
Left TPA2(cm2)8.19±3.207.70±3.27−0.480.61
Right psoasHU135.95±10.8639.34±10.273.380.28
Right psoasHU230.55±13.0036.40±10.655.830.10
Left psoasHU138.49±10.3541.86±10.993.370.29
Left poasHU234.68±11.9937.86±9.693.180.33

STROBE checklist for the study’s methods

Study designCohort, observational, retrospective and monocentric
Setting
  • Anaesthesia and Intensive Care Unit, Târgu Mureș Emergency County Clinical Hospital, Romania

  • Period of recruitment: August 2020 – December 2022

  • Exposure: COVID-19

  • Follow-up: two psoas CT scans

  • Data collection: electronic medical and imagistic records

ParticipantsEligibility criteria: ≥ 18 years of age admitted in the ICU for at least 24 hours, positively tested for SARS-COV2 by real-time polymerase chain reaction (RT-PCR), and who had two eligible CT scans for psoas analysis
Variables
  • Main outcomes: analysis of the changes in psoas area and psoas HU in critically ill

  • Predictors: length of stay in hospital, length of stay in ICU, mechanical ventilation

  • Diagnostic criteria: psoas analysis by CT scan

Data sources/measurement
  • Data sources: Picture Archiving and Communicating System and RadiAnt DICOM Viewer

  • Measurement: Psoas muscle area and density (HU) were measured at the level of the third lumbar vertebrae

Study sizeInclusion of critically ill patients who were hospitalized in the ICU for more than 24h, adults, that had two eligible CT scans for psoas assessment
Statistical methods
  • To conduct the statistical analysis, SPSS, version 27 (SPSS Inc. Chicago, IL, USA) was utilized.

  • Continuous data are presented as medians (minimum-maximum) or means (±standard deviation) and categorical data as proportions.

  • The Kolmogorov–Smirnov test was used to assess the normal distribution of continuous numerical variables. The Mann-Whitney U test was used for non-Gaussian variables, and Student’s t-test was used for the Gaussian continuous variables.

  • Inter-variability is performed by Bland and Altman methods.

  • Receiver operating characteristics curve analysis was performed.

  • Area under the curve values were displayed including a 95% confidence interval.

  • For correlations, Spearman’s coefficients were used.

  • A p-value of less than 0.05 was considered statistically significant.

LOS in hospital and LOS ICU correlations with psoas area and HU

CT scan (mean A+B)LOSRight psoas (cm2)Right psoas (HU)Left psoas (cm2)Left psoas (HU)
Correlation coefficientPCorrelation coefficientpCorrelation coefficientpCorrelation coefficientp
CT scan1Hospital0.0150.940.2020.36−0.0540.8100.3620.09
ICU−0.3490.110.4170.02−0.3220.110.6660.01

CT scan2Hospital−0.0870.70−0.1980.37−0.0690.76−0.0070.97
ICU−0.3070.160.0070.97−0.2630.230.2500.26
DOI: https://doi.org/10.2478/jccm-2023-0026 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 218 - 229
Submitted on: Jun 19, 2023
Accepted on: Sep 19, 2023
Published on: Nov 14, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2023 Oana Elena Branea, Anca Gabriela Vlad, Mihai Pui, Diana Andreea Becica, Mihai Emanuel Becica, AnaMaria Romina Budeanu, Razvan Gabriel Budeanu, Florin Stoica, Alexandra Elena Lazar, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.